The Michael J. Fox Foundation for Parkinson’s Research (MJFF) recognized a Texas scientist for his contributions to Parkinson’s research and his commitment to mentoring the next generation of Parkinson’s scientists. Claudio Soto, PhD, a professor
The FDA’s approval of the first and only subcutaneous 24-hour infusion of levodopa-based therapy. Top-line results from the Exenatide-PD3 study. ADHD and Parkinson’s. …
Every prescription drug used to treat Parkinson’s (or any other condition) in the US has been tested in clinical trials prior to gaining approval by the …
ALS’s links to Parkinson’s. A “Parkinson’s Belt” in the United States. SGLT2 inhibitors for risk reduction. New research on “gut-first” Parkinson’s. Brett Favre …
![[PODCAST]Stem Cells, Cell Replacement, and Parkinson’s – A Conversation with Dr. Roger Barker](https://www.shufflernews.com/wp-content/uploads/2024/09/image004-300x107-1.png)
This episode is an interview with Roger Barker, Professor of Clinical Neuroscience and Honorary Consultant in Neurology, at the University of Cambridge and Addenbrooke’s …